title: Effects of combined insulin-sulfonylurea therapy in type II patients.
abstract: We conducted a double-blind crossover study to determine which patient characteristics best predict a beneficial response to combined insulin-glyburide therapy. Glyburide (15 mg/day) or placebo was added to the treatment regimen of 31 insulin-treated type II (non-insulin-dependent) diabetic subjects. During glyburide therapy, there was a significant improvement in glycemic control with a reduction in glycosylated hemoglobin from 9.9 +/- 1.3 to 9.1 +/- 1.3% (P less than .001). Patients who responded had higher fasting C-peptide levels (P less than .001) and shorter durations of insulin therapy (P less than .01) than those who did not respond. Glyburide withdrawal was associated with a greater than expected deterioration in glycemic control. Patients on insulin therapy for greater than 8 yr are unlikely to benefit significantly from the addition of glyburide to their treatment regimen.
authors.affiliation: Department of Endocrinology, Repatriation General Hospital, Sydney, Australia.
authors.forename: M S
authors.initials: MS
authors.lastname: Lewitt
authors.forename: V K
authors.initials: VK
authors.lastname: Yu
authors.forename: G C
authors.initials: GC
authors.lastname: Rennie
authors.forename: J N
authors.initials: JN
authors.lastname: Carter
authors.forename: G M
authors.initials: GM
authors.lastname: Marel
authors.forename: D K
authors.initials: DK
authors.lastname: Yue
authors.forename: M J
authors.initials: MJ
authors.lastname: Hooper
mesh_terms: D000368:Aged; D001786:Blood Glucose / Q000032:analysis; D002096:C-Peptide / Q000097:blood; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D005905:Glyburide / Q000627:therapeutic use*; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007328:Insulin / Q000627:therapeutic use*; D008297:Male
chemical_list: D001786:Blood Glucose; D002096:C-Peptide; D005905:Glyburide; D006442:Glycated Hemoglobin; D007328:Insulin